Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **transient receptor potential canonical 5 channel (TRPC5)** is a calcium-permeable, nonselective cation channel belonging to the TRPC subfamily of ion channels. As a homotetrameric membrane protein, TRPC5 is widely expressed in various tissues including the brain, kidney, heart, vasculature, and gastrointestinal tract. It plays crucial roles in cellular calcium signaling and is activated downstream of G protein–coupled receptor pathways, usually via phospholipase C activation. TRPC5 is of considerable pharmacological interest as a therapeutic target in kidney disease, depression, anxiety, and cardiovascular disorders, with increasing efforts directed at small-molecule inhibitor development. Unlike some other TRPC channels, TRPC5 has distinctive structural features in its pore-forming region and demonstrates unique electrophysiological properties, such as double-rectifying current-voltage relationships and sensitivity to redox state via an extracellular disulfide bond. Structural and functional studies continue to reveal detailed mechanisms of gating, ion selectivity, and pharmacological modulation relevant to disease mechanisms and drug development [1][2][3][4][5].
Inhibition or modulation of TRPC5 channel reduces calcium influx, which can ameliorate disease-associated processes such as fibrosis in kidney disease and excessive neuronal excitability in mood disorders [2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient receptor potential canonical 5 channel (TRPC5).